A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease-Reference-Cited by-同舟云学术

A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease

Published:2009-08-15 Issue:4 Volume:125 Page:879-886
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Brinkrolf Peter,Landmeier Silke,Altvater Bianca,Chen Christiane,Pscherer Sibylle,Rosemann Annegret,Ranft Andreas,Dirksen Uta,Juergens Heribert,Rossig Claudia

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference63 articles.

1. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European intergroup cooperative Ewing sarcoma Studies;Paulussen;Ann Oncol,1998

2. Results of the EICESS-92 study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients;Paulussen;J Clin Oncol,2008

3. A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomas;Mackall;Clin Cancer Res,2008

4. Early lymphocyte recovery as a prognostic indicator for high-risk Ewing sarcoma;De Angulo;J Pediatr Hematol Oncol,2007

5. Differential expression of leukocyte differentiation antigens in small round blue cell sarcomas;Mechtersheimer;Cancer,1993

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges;Cancers;2024-06-12

2. Bone Marrow: The Central Immune System;Immuno;2023-08-03

3. Targeted immune activation in pediatric solid tumors: opportunities to complement local control approaches;Frontiers in Immunology;2023-06-22

4. Prospects and Advances in Adoptive Natural Killer Cell Therapy for Unmet Therapeutic Needs in Pediatric Bone Sarcomas;International Journal of Molecular Sciences;2023-05-05

5. Current Landscape of Immunotherapy for Advanced Sarcoma;Cancers;2023-04-13